Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
Status:
Unknown status
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the treatment response of metformin, Peg-IFN and
ribavirin combination therapy for chronic hepatitis C virus (HCV).